A eutectic lidocaine-benzocaine emulsion with aqueous bupivacaine delivers multi-day local pain relief while avoiding opioid use.
PVA-coated crystalline anesthetic microparticles curb burst release and maintain postsurgical pain relief for 72 to 96 hours.
Multivesicular liposomes gradually release bupivacaine at the stellate ganglion, extending arrhythmia suppression while limiting abrupt exposure.
This case combines a thermoplastic elastomer with fatty esters to improve local anesthetic patch permeability, adhesion, and cohesion.
Exosome-loaded anesthetics target nerve axons for sustained blockade while reducing systemic exposure and toxicity.
A multi-aperture cannula supports continuous subcutaneous cannabinoid delivery with prolonged anesthesia and less tissue trauma.